Advanced Proteome Therapeutics Corporation (APTCF) Research

Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.

Market snapshot

Symbol
APTCF
Price
$0.00
Day change
+0.00%
Market cap
$149.6K
P/E ratio
0.01x
52-week range
0.0002-0.0002
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aladdin Healthcare Technologies SE (ALDNF)
  • Eden Empire Inc. (EDNEF)
  • Hemogenyx Pharmaceuticals Plc (HOPHF)
  • TuHURA Biosciences, Inc. (HURA)
  • MedMen Enterprises Inc. (MMNFF)
  • Propanc Biopharma, Inc. (PPCB)
  • Predictive Technology Group, Inc. (PRED)
  • Pivotal Therapeutics Inc. (PVTTF)

Open Advanced Proteome Therapeutics Corporation (APTCF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.